Largan Health AI-TECH sleep detector "DOMII " ,is the first product to be certified by the Taiwan Society of Sleep Medicine

Largan Health AI-TECH sleep detector "DOMII " ,is the first product to be certified by the Taiwan Society of Sleep Medicine

Did you sleep well last night? Is it because of work stress, taking care of children, or long hours of driving that your sleep quality is deteriorating? A survey by the Taiwan Society of Sleep Medicine found that the prevalence of chronic insomnia in Taiwan is 10.7%, estimating that there are at least 2 million people in Taiwan who suffer from chronic insomnia. Sleep disorders such as insomnia, sleep apnea, and narcolepsy can have a significant impact on both physical and mental health. In the long run, they may become risk factors for conditions like high blood pressure, depression, and substance abuse.

Poor sleep is considered the root of health problems. Research shows that those who get less than 6 hours of sleep have a 200% higher risk of heart disease and stroke compared to the general population. The American Academy of Sleep Medicine also points out that sleep is relevent to various serious complications, including cardiovascular issues. In Taiwan, one in ten people suffers from sleep disorders, with "sleep apnea" being the primary factor and often the most ignored disease. 


Unlike previously complicated sleep detector, Largan Health AI-TECH is dedicated to developing a simple and at-home sleep testing device . Through lightweight and comfortable features , it allows individuals with sleep disorders to undergo sleep testing at home, turning their homes into monitoring stations and providing a more accurate reflection of their sleep conditions.

The Largan Health AI-Tech “DOMII”utilizes cutting-edge wireless sensing technology to faithfully record and present nighttime sleep patterns in a convenient, high-quality, and non-intrusive manner. It effectively assists doctors in diagnosing and analyzing patients' sleep disorders, enabling the formulation of tailored sleep treatment plans to help improve the sleep quality of those with sleep disorders. Patients do not need to stay in the hospital or sleep center; they can undergo sleep testing in the comfort of their homes, making it convenient for long-term monitoring and treatment tracking.

The “DOMII” sleep detector is a small device, roughly such as an Oreo cookie. This testing equipment is non-intrusive and doesn't disrupt the sleep of the person being tested. Subjects simply attach the “DOMII” to their chest and combine with oxygen blood monitoring before going to bed. After a night's sleep, the detector can analyze and record the entire night's sleep structure, including the sleep apnea index and the times it occurs. This helps individuals clearly understand their sleep patterns.

During the Taiwan Society of Sleep Medicine Annual Meeting on October 2022, Taipei Veterans General Hospital, China Medical University Hospital and Hualien Tzu Chi Hospital jointly presented the results of clinical validation comparing the "DOMII" detector with traditional Polysomnography (PSG). The analysis showed that "DOMII" had high accuracy, sensitivity, and specificity.

Refer to the theory of cardiopulmonary coupling (CPC) from Harvard Medical School, Largan Health AI-Tech has spent several years collaborating with sleep medicine experts and integrating ICT-AI technology to create the first medical-grade sleep detector “DOMII”. It allows docters and the public to measure physiological signals during nighttime sleep in a more comfortable and precise manner. It enables the analysis of various physiological information, including sleep apnea, sleep quality, sleep posture, body movements, nocturnal awakenings, heart rate variability (HRV), oxygen desaturation, electrocardiogram data, arrhythmia screening, autonomic nervous system dysfunction, and more.

Statistics indicate that over 1.56 million males aged 40 and above in Taiwan suffer from sleep apnea. However, based on national health insurance data, the number of people seeking medical attention for this condition is less than 120,000, with a healthcare utilization rate of less than 1%. This discrepancy suggests that millions of people are still at risk due to sleep apnea. Unfortunately, Taiwan's sleep testing resources are limited and unevenly distributed. Largan Health AI-Tech has transformed academic theories into precise products that not only facilitate clinical use but also enable large-scale screening of potential patients, contributing to the promotion of better sleep health for the global.